SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Doug Bean who wrote (1443)10/15/1999 10:49:00 AM
From: vestor  Read Replies (1) of 1837
 
Given all the recent approvals and business aliances and the 1.25 Cenestin dosage is just around the corner to me the downside risk at $8. is very samll and the upside potential is very good. I am not factoring that someone (Solvey or Warner or ?) may find DRMD an interesting aquisition given their potential.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext